The Interplay Between Accumulation of Amyloid-Beta and Tau Proteins, PANoptosis, and Inflammation in Alzheimer's Disease

Overview

Journal Neuromolecular Med

Specialty Biochemistry

Date 2025 Jan 3

PMID 39751702

Authors

Xianbo Zhuang

Jie Lin

Yamin Song

Ru Ban

Xin Zhao

Zhangyong Xia

Zheng Wang

Guifeng Zhang

Affiliations

Soon will be listed here.

Abstract

Alzheimer's disease (AD) is a common progressive neurodegenerative disorder, and the vast majority of cases occur in elderly patients. Recently, the accumulation of Aβ and tau proteins has drawn considerable attention in AD research. This review explores the multifaceted interactions between these proteins and their contribution to the pathological landscape of AD, encompassing synaptic dysfunction, neuroinflammation, and PANoptosis. PANoptosis is a collective term for programmed cell death (PCD) modalities that encompass elements of apoptosis, pyroptosis, and necroptosis. The accumulation of Aβ peptides and tau proteins, along with the immune response in brain cells, may trigger PANoptosis, thus advancing the progression of the disease. Recent advancements in molecular imaging and genetics have provided deeper insights into the interactions between Aβ peptides, tau proteins, and the immune response. The review also discusses the role of mitochondrial dysregulation in AD. The exploration of the interplay between neurodegeneration, immune responses, and cell death offers promising avenues for the development of innovative treatments.

Citing Articles

SP3-Mediated Transcriptional Activation of GRIK1 is Involved in Alzheimer's Disease-Induced Cognitive Decline by Inducing Inflammasome Activation in Microglia.

Pang X, Wang Z, Zhang M, Dong J, Dong Z, Yin Y Neuromolecular Med. 2025; 27(1):22.

PMID: 40055261 DOI: 10.1007/s12017-025-08844-2.

References

Alquezar C, Arya S, Kao A . Tau Post-translational Modifications: Dynamic Transformers of Tau Function, Degradation, and Aggregation. Front Neurol. 2021; 11:595532. PMC: 7817643. DOI: 10.3389/fneur.2020.595532. View

Atagi Y, Liu C, Painter M, Chen X, Verbeeck C, Zheng H . Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2). J Biol Chem. 2015; 290(43):26043-50. PMC: 4646257. DOI: 10.1074/jbc.M115.679043. View

Bae H, Jang Y, Karki R, Han J . Implications of inflammatory cell death-PANoptosis in health and disease. Arch Pharm Res. 2024; 47(7):617-631. DOI: 10.1007/s12272-024-01506-0. View

Balusu S, De Strooper B . The necroptosis cell death pathway drives neurodegeneration in Alzheimer's disease. Acta Neuropathol. 2024; 147(1):96. PMC: 11162975. DOI: 10.1007/s00401-024-02747-5. View

Barbier P, Zejneli O, Martinho M, Lasorsa A, Belle V, Smet-Nocca C . Role of Tau as a Microtubule-Associated Protein: Structural and Functional Aspects. Front Aging Neurosci. 2019; 11:204. PMC: 6692637. DOI: 10.3389/fnagi.2019.00204. View

Bettcher B, Tansey M, Dorothee G, Heneka M . Peripheral and central immune system crosstalk in Alzheimer disease - a research prospectus. Nat Rev Neurol. 2021; 17(11):689-701. PMC: 8439173. DOI: 10.1038/s41582-021-00549-x. View

Bloom G . Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol. 2014; 71(4):505-8. DOI: 10.1001/jamaneurol.2013.5847. View

Botella Lucena P, Heneka M . Inflammatory aspects of Alzheimer's disease. Acta Neuropathol. 2024; 148(1):31. DOI: 10.1007/s00401-024-02790-2. View

Braak H, Braak E . Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991; 82(4):239-59. DOI: 10.1007/BF00308809. View

10.

Braak H, Thal D, Ghebremedhin E, Del Tredici K . Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol. 2011; 70(11):960-9. DOI: 10.1097/NEN.0b013e318232a379. View

11.

Caccamo A, Branca C, Piras I, Ferreira E, Huentelman M, Liang W . Necroptosis activation in Alzheimer's disease. Nat Neurosci. 2017; 20(9):1236-1246. DOI: 10.1038/nn.4608. View

12.

Calvo-Rodriguez M, Kharitonova E, Snyder A, Hou S, Sanchez-Mico M, Das S . Real-time imaging of mitochondrial redox reveals increased mitochondrial oxidative stress associated with amyloid β aggregates in vivo in a mouse model of Alzheimer's disease. Mol Neurodegener. 2024; 19(1):6. PMC: 10797952. DOI: 10.1186/s13024-024-00702-2. View

13.

Casas-Tinto S, Zhang Y, Sanchez-Garcia J, Gomez-Velazquez M, Rincon-Limas D, Fernandez-Funez P . The ER stress factor XBP1s prevents amyloid-beta neurotoxicity. Hum Mol Genet. 2011; 20(11):2144-60. PMC: 3090193. DOI: 10.1093/hmg/ddr100. View

14.

Cha M, Han S, Son S, Hong H, Choi Y, Byun J . Mitochondria-specific accumulation of amyloid β induces mitochondrial dysfunction leading to apoptotic cell death. PLoS One. 2012; 7(4):e34929. PMC: 3325919. DOI: 10.1371/journal.pone.0034929. View

15.

Chen S, Peng J, Sherchan P, Ma Y, Xiang S, Yan F . TREM2 activation attenuates neuroinflammation and neuronal apoptosis via PI3K/Akt pathway after intracerebral hemorrhage in mice. J Neuroinflammation. 2020; 17(1):168. PMC: 7257134. DOI: 10.1186/s12974-020-01853-x. View

16.

Chen Y, Yu Y . Tau and neuroinflammation in Alzheimer's disease: interplay mechanisms and clinical translation. J Neuroinflammation. 2023; 20(1):165. PMC: 10349496. DOI: 10.1186/s12974-023-02853-3. View

17.

Choi E, Kim M, Park S . Targeting Mitochondrial Dysfunction and Reactive Oxygen Species for Neurodegenerative Disease Treatment. Int J Mol Sci. 2024; 25(14). PMC: 11277296. DOI: 10.3390/ijms25147952. View

18.

Choi S, Kwon S, Kim J, Ahn N, Lee J, Yang S . The Molecular Mechanisms of Neuroinflammation in Alzheimer's Disease, the Consequence of Neural Cell Death. Int J Mol Sci. 2023; 24(14). PMC: 10380735. DOI: 10.3390/ijms241411757. View

19.

Choudhury S, Sarkar R, Karki R, Kanneganti T . A comparative study of apoptosis, pyroptosis, necroptosis, and PANoptosis components in mouse and human cells. PLoS One. 2024; 19(2):e0299577. PMC: 10898734. DOI: 10.1371/journal.pone.0299577. View

20.

Clayton K, Delpech J, Herron S, Iwahara N, Ericsson M, Saito T . Plaque associated microglia hyper-secrete extracellular vesicles and accelerate tau propagation in a humanized APP mouse model. Mol Neurodegener. 2021; 16(1):18. PMC: 7986521. DOI: 10.1186/s13024-021-00440-9. View